Back to Search Start Over

Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient.

Authors :
Saettini, F.
Radaelli, S.
Ocello, L.
Ferrari, G. M.
Corti, P.
Dell'Acqua, F.
Ippolito, D.
Foresti, S.
Gervasini, C.
Badolato, R.
Biondi, A.
Source :
Pediatric Hematology & Oncology; Feb 2022, Vol. 39 Issue 1, p74-79, 6p
Publication Year :
2022

Abstract

Rubinstein–Taybi syndrome (RSTS) is an autosomal dominant disorder, caused by variants in CREBBP or EP300. Affected individuals present with distinctive craniofacial features, broad thumbs and/or halluces, intellectual disability and immunodeficiency. Here we report on one RSTS patient who experienced hemophagocytic lymphohystiocytosis (HLH) and disseminated herpes virus 1 (HSV-1) disease. The clinical picture of RSTS is expanding to include autoinflammatory, autoimmune, and infectious complications. Prompt treatment of HLH and disseminated HSV-1 can lower the mortality rate of these life-threatening conditions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08880018
Volume :
39
Issue :
1
Database :
Complementary Index
Journal :
Pediatric Hematology & Oncology
Publication Type :
Academic Journal
Accession number :
154955822
Full Text :
https://doi.org/10.1080/08880018.2021.1928802